|
State of California-Heatth and Welfare Agency Department of Health Services
<br /> Page 3 of 7 pages
<br /> RADIOACTIVE MATERIAL LICENSE license Number: 1276-39
<br /> Supplementary Sheet Amendment Number 65
<br /> F. Group 6 Brachytherapy and Ophthalmic treatments utilizing sealed or solid sources manufactured, labeled,
<br /> packaged, and distributed in accordance with a specific license issued pursuant to Title 10, Code
<br /> of Federal Regulations, Part 32.74, or a specific license issued by an agreement state pursuant to
<br /> equivalent state regulations (except for sources manufactured prior to August 16, 1974).
<br /> L-4. Brachytherapy
<br /> 5. Applicator
<br /> G. Group 9 Marker and calibration sources.
<br /> LICENSE CONDITIONS
<br /> 10. Radioactive material shall be used only at the following locations:
<br /> (a) 1800 North California Street, Stockton, California.
<br /> 11. This license is subject to an annual fee for sources of radioactive material authorized to be possessed at any one
<br /> time as specified in items 6, 7, 8 and 9 of this license. The annual fee for this license is required by and
<br /> computed in accordance with Title 17,California Code of Regulations,Sections 30230-30232 and is also subject
<br /> to an annual cost-of-living adjustment pursuant to Section 100425 of the California Health and Safety Code.
<br /> 12. The individuals named below are authorized the specific uses of radioactive material described in Items 6, 7,
<br /> 8 and 9 of this license as follows:
<br /> (a) J. David Bernard, M.D. Groups 1, 2, 3, 4, 5, and 9
<br /> (b) T. A. Thomas, M.D. Groups 1, 2, 3, 4 (1-131 only), 5, and 9
<br /> (c) Laszlo B. Fodor, M.D. Groups 1, 2, 3, 4 (I-131 only), 5, and 9
<br /> (d) Javad Jamshidi, M.D. Groups 1, 2, 3, 4 (1-131 only), 5 and 9
<br /> (e) Daniel W. Terry, M.D. Groups 1, 2, 3, 4 (I-131 only), 5, and 9
<br /> (f) Jack L. Funamura, M.D. Groups 1, 2, 3, 4 (1-131 only), 5, and 9
<br /> (g) M. Lousie Del Paine, M.D. Groups 1, 2, 3, and 9
<br /> (h) Masanobu Kamigaki, M.D. Groups 1, 2, 3, and 9
<br /> (i) Lynett Hart, M.D. Group 6
<br /> 0) Henry Y. T. Wong, M.D. Groups 4 (P-32 and Sr-89 only), and 6
<br /> (k) Edward C. Greenleaf, M.D. Groups 4 (Strontium 89 only), 6, and 9
<br /> (I) Royce J. Biddle, M.D. Groups 1, 2, 3, and 9
<br /> (m) James D. Rooke, M.D. Groups 4 (thyroid therapy only), and 5
<br /> (n) Frank S. Callcott, M.D. Groups 1, 2, 3, 4, 5, and 9
<br /> (o) William N. Gonser, M.D. Groups 1, 2, 3, and 9
<br /> (p) Virginia Lee Toombs, M.D. Groups 1, 2, 3, and 9
<br /> (q) Ramesh N. Dharawat, M.D. Group 2 (Cardiac studies only) and 9
<br /> (s) Thomas M. Bey, M.D. Group 1, 2, 3, and 9
<br />
|